Mprf Mutations in Methicillin-Resistant Staphylococcus Aureus Confer Reduced Susceptibility to Biocides and Daptomycin

Mengzhen Chen,Haiping Wang,Shengnan Jiang,Shujuan Ji,Yunsong Yu,Yan Chen
DOI: https://doi.org/10.1016/j.cmi.2023.12.021
IF: 13.31
2023-01-01
Clinical Microbiology and Infection
Abstract:We read the article by Wendel et al. [1], which provides a novel mechanism underlying the emergence of daptomycin-resistant Staphylococcus aureus in clinical practice, with great interest. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most prevalent multidrug-resistant pathogen worldwide. Daptomycin (DAP) is the primary therapeutic choice for MRSA infections, and the emergence of DAP-resistant MRSA is a matter of substantial concern [2]. In a study conducted by Wendel et al., clinical DAP-resistant S.
What problem does this paper attempt to address?